Dr. Michael Scordo

Dr. Michael Scordo, MD, is a medical oncologist and hematologist specializing in blood cancers, with a focused expertise in stem cell transplantation and cellular therapies, including chimeric antigen receptor (CAR) T cell therapy. He holds an appointment on the Adult Bone Marrow Transplant Service and the Cellular Therapy Service, where he works as part of a multidisciplinary team that includes nurses, advanced practice providers, nurse coordinators, social workers, and case managers. His clinical interests center particularly on lymphoma and multiple myeloma, and he brings a collaborative, patient-centered approach to the care of individuals navigating complex hematologic conditions.

Dr. Scordo's clinical research is focused on improving outcomes for patients undergoing stem cell transplantation and cellular therapies. His work centers on identifying new strategies to reduce treatment-related side effects and toxicity, as well as personalizing the chemotherapy and immunotherapy regimens administered prior to transplantation and cellular therapy. Through this research, he aims to refine conditioning approaches, minimize adverse effects, and ultimately improve the overall treatment experience and outcomes for patients with blood cancers.

Beyond his research and clinical responsibilities, Dr. Scordo is deeply committed to delivering compassionate and personalized care. He prioritizes providing patients and their families with clarity and balance during what is often a stressful and complicated treatment journey. Working alongside a dedicated team of specialists, he strives to offer cohesive support at every stage of care, combining scientific rigor with a genuine focus on the human experience of illness and recovery.